After
the Food and Drug Administration voted in favor of administering Moderna’s
COVID-19 vaccine to children ages 6-11, that same committee will vote on
whether children under 6 years old will become eligible for the vaccine.
Children
under 6 are now the lone group not eligible for the COVID-19 vaccine. According
to recent data from the FDA, the Pfizer vaccine when administered in three
doses is effective at preventing the virus in children ages 6 months to 4
years.
Another
FDA document shows that Moderna’s vaccine for children in that same age range
is effective.
The
FDA advisory committee will vote Wednesday on whether to grant emergency use
authorization for both of these vaccines for children as young as 6 months
old.